Subsequent analysis suggested that hepatic steatosis developed as a result of decreased ceramide production in the intestine, a process involving a direct gene target of HIF-2, Neu3 (neuraminidase 3) [101]. The gene discussed is NEU3; the disease is fatty liver disease.